Lasofoxifene Phase III Program for Metastatic Breast Cancer
Search documents
Athira Pharma, Inc. (ATHA) Discusses Acquisition of Rights to Lasofoxifene Phase III Program for Metastatic Breast Cancer Transcript
Seeking Alphaยท 2025-12-18 18:47
PresentationHello, ladies and gentlemen. Thank you for standing by, and welcome to the Athira Pharma conference call. [Operator Instructions] Please be advised that today's conference call may be recorded. I would now like to hand the conference call over to Julie Rathbun, Head of Investor and Public Relations with Athira, please go ahead.Julie RathbunHead of Investor Relations Thank you, operator. Good morning, and welcome to the Athira Pharma conference call to discuss the transformative transactions anno ...